Lubrijoint Activ Tablet

The combined action of these two compounds is believed to promote cartilage repair, reduce inflammation, and alleviate joint pain associated with osteoarthritis and other degenerative joint conditions. Lubrijoint Activ is indicated for patients experiencing mild to moderate joint discomfort, stiffness, and reduced mobility. It may help improve joint function and slow the progression of cartilage degradation.

The tablet is intended for oral administration, typically taken once or twice daily as directed by a healthcare professional. While generally well tolerated, some patients may experience mild gastrointestinal symptoms such as nausea or diarrhea. Lubrijoint Activ should be used under medical supervision, especially in individuals with shellfish allergies or those on anticoagulant therapy.

Regular monitoring and adherence to prescribed dosage are recommended to achieve optimal therapeutic outcomes.